Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat

Mild-to-moderate hypertension is often associated with insulin resistance and visceral adiposity. Whether these metabolic abnormalities have an independent impact on regional cardiac function is not known. The goal of this study was to investigate the effects of increased blood pressure, insulin resistance, and ectopic fat accumulation on the changes in peak systolic circumferential strain. Thirty-five male subjects (age: 47±1 years; body mass index: 28.4±0.6 kg.m−2; mean±SEM) included 13 with normal blood pressure (BP: 113±5/67±2 mm Hg), 13 with prehypertension (BP: 130±1/76±2 mm Hg), and 9 newly diagnosed with essential hypertension (BP: 150±2/94±2 mm Hg) who underwent cardiac magnetic resonance tissue tagging (MRI) and MRI quantitation of abdominal visceral and epicardial fat. Glucose tolerance, on oral glucose tolerance test, and insulin resistance were assessed along with the serum lipid profile. All of the subjects had normal glucose tolerance, left- and right-ventricular volumes, and ejection fraction. Across the BP groups, left ventricular mass tended to increase, and circumferential shortening was progressively reduced at basal, midheart, and apical segments (on average, from −17.0±0.5% in normal blood pressure to −15.2±0.7% in prehypertension to −13.6±0.8% in those newly diagnosed with essential hypertension; P=0.004). Reduced circumferential strain was significantly associated with raised BP independent of age (r=0.41; P=0.01) and with epicardial and visceral fat, serum triglycerides, and insulin resistance independent of age and BP. In conclusion, regional left ventricular function is already reduced at the early stages of hypertension despite the normal global cardiac function. Insulin resistance, dyslipidemia, and ectopic fat accumulation are associated with reduced regional systolic function.

[1]  Arya M. Sharma,et al.  Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. , 2007, Current pharmaceutical design.

[2]  H. Sacks,et al.  Human epicardial adipose tissue: a review. , 2007, American heart journal.

[3]  S W Rabkin,et al.  Epicardial fat: properties, function and relationship to obesity , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[4]  R M Siervogel,et al.  Validity of a new automated software program for visceral adipose tissue estimation , 2007, International Journal of Obesity.

[5]  Benjamin J. Epstein,et al.  Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure , 2007 .

[6]  S. Lai,et al.  Hypertension and smoking are associated with reduced regional left ventricular function in asymptomatic: individuals the Multi-Ethnic Study of Atherosclerosis. , 2006, Journal of the American College of Cardiology.

[7]  S. Grundy,et al.  Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. , 2006, Journal of the American College of Cardiology.

[8]  A. Ferrannini Pathogenesis and Clinical Features of Obesity and Insulin Resistance , 2006 .

[9]  R. Bonser,et al.  Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease , 2006, Cardiovascular diabetology.

[10]  A. Divani,et al.  Prehypertension as a Risk Factor for Cardiovascular Diseases , 2006, The Journal of cardiovascular nursing.

[11]  Leon Axel,et al.  Tagged Magnetic Resonance Imaging of the Heart: a Survey , 2004 .

[12]  William C Stanley,et al.  Myocardial substrate metabolism in the normal and failing heart. , 2005, Physiological reviews.

[13]  R. Unger,et al.  Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone. , 2005, American journal of physiology. Endocrinology and metabolism.

[14]  Luigi Landini,et al.  An accurate and robust method for unsupervised assessment of abdominal fat by MRI , 2004, Journal of magnetic resonance imaging : JMRI.

[15]  M. Lombardi,et al.  Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function , 2004, Hypertension.

[16]  M. Sivananthan,et al.  Role of MRI in clinical cardiology , 2004, The Lancet.

[17]  Donald D Hensrud,et al.  Splanchnic lipolysis in human obesity. , 2004, The Journal of clinical investigation.

[18]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[19]  B. Goldstein,et al.  Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators , 2003, Circulation.

[20]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[21]  Philippe Geslin,et al.  3-D MRI assessment of regional left ventricular systolic wall stress in patients with reperfused MI. , 2003, American journal of physiology. Heart and circulatory physiology.

[22]  Andrea Mari,et al.  Mathematical modeling in glucose metabolism and insulin secretion , 2002, Current opinion in clinical nutrition and metabolic care.

[23]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[24]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[25]  D. Levy,et al.  Impact of high-normal blood pressure on the risk of cardiovascular disease. , 2002, The New England journal of medicine.

[26]  Andrea Mari,et al.  A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test , 2001 .

[27]  Kim Rajappan,et al.  The role of cardiovascular magnetic resonance in heart failure , 2000, European journal of heart failure.

[28]  Jerry L Prince,et al.  Visualizing myocardial function using HARP MRI. , 2000, Physics in medicine and biology.

[29]  Jerry L Prince,et al.  Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI. , 2000, Circulation.

[30]  L. Orci,et al.  Lipotoxic heart disease in obese rats: implications for human obesity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Saad,et al.  Insulin resistance in essential hypertension. , 1990, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[32]  L. Axel,et al.  MR imaging of motion with spatial modulation of magnetization. , 1989, Radiology.

[33]  C. Palombo,et al.  Hypertension: a metabolic disorder? , 1989, Diabete & metabolisme.

[34]  C. Pond,et al.  Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. , 1989, Comparative biochemistry and physiology. B, Comparative biochemistry.

[35]  W. S. Snyder,et al.  Report of the task group on reference man , 1979, Annals of the ICRP.